We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CLI:MILCentrale del Latte d'Italia S.p.A. Analysis

Data as of 2026-03-11 - not real-time

€4.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Centrale del Latte d'Italia trades at €4.50, comfortably below its 20‑day (€4.86) and 50‑day (€4.93) moving averages, signaling short‑term weakness, while remaining above the 200‑day average, indicating a longer‑term base. RSI at 36 points to oversold conditions, yet the MACD histogram stays negative, suggesting bearish momentum persists. The stock’s valuation appears attractive: a PE of ~13 and PB of 0.81 are well under industry norms, and the discounted cash‑flow model implies a fair value near €31, translating to a theoretical upside of over 30% versus the current price. However, the company’s fundamentals show modest revenue growth (≈1%), thin profit margins (≈1.4%), and a high debt‑to‑equity ratio of ~116%, raising concerns about financial resilience.
Market sentiment is buoyant, reflected by an “Extreme Greed” index, and trading volume is on the rise, yet volatility remains elevated at roughly 46% and beta hovers near zero, indicating price swings are driven more by company‑specific factors than broader market moves. The absence of a dividend further limits income‑focused appeal, positioning the stock primarily as a value play for investors willing to tolerate the operational and leverage risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at €4.32
  • RSI indicating oversold conditions
  • Bearish MACD momentum despite rising volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation upside implied by DCF and low PE/PB
  • Stable consumer‑defensive sector with low cyclicality
  • Forward EPS guidance shows improving earnings

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage and thin profit margins limit upside
  • No dividend payout reduces total return potential
  • Long‑term sector stability offsets operational risks

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin1.35%
P/E Ratio12.9
ROE6.33%
ROA2.05%
Debt/Equity115.93
P/B Ratio0.8
Op. Cash Flow€35.8M
Free Cash Flow€29.6M

Technical Analysis

TrendNeutral
RSI35.9
Support€4.32
Resistance€5.30
MA 20€4.86
MA 50€4.93
MA 200€3.92
MACDBearish
VolumeIncreasing
Fear & Greed Index76.64

Valuation

Fair Value€30.91
Target Price€6.00
Upside/Downside33.33%
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.09
Volatility46.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.